 |
|
 |
Circe Biomedical's lead product, the HepatAssist® System, which is currently in clinical development, is an extracorporeal liver support system incorporating primary hepatocytes, and is designed to treat patients with liver failure by temporarily providing essential liver functions.
The company's PancreAssist® System, which is in preclinical development, is an implantable bioartificial pancreas, incorporating pancreatic islets, and is designed as a novel therapy for the treatment of insulin-dependent diabetes.
|
Home | Company | Technology | Clinical Trials | News | Contact
Copyright © 1999 Circe Biomedical. All rights reserved worldwide.
HepatAssist and PancreAssist are registered trademarks of Circe Biomedical.
|
|
